Á¦¸ñ: SNUBI > 11 ¿ù > 6 ÀÏ Çà»ç > default:

1. ÈÄ´Ï-¿¹ºñ±º  

 Ç׸ñ: ÀϽÃ

2003. 11. 6

 Ç׸ñ: ³»¿ë

³ª¶ó ÁöŰ·¯ °©´Ï´Ù.

2. ¾à¹°À¯Àüü ¿¬±¸ÀÇ ÀÓ»óÀû¿ë ±¹Á¦½ÉÆ÷Áö¿ò  

 Ç׸ñ: ÀϽÃ

2003. 11. 6

 Ç׸ñ: ³»¿ë

¾à¹°À¯Àüü ¿¬±¸ÀÇ ÀÓ»óÀû¿ë ±¹Á¦½ÉÆ÷Áö¿ò

º» ½ÉÆ÷Áö¿ò¿¡¼­´Â ¾à¹°À¯Àüü ¿¬±¸ÀÇ ±¹³»¡¤¿Ü Àü¹®°¡¸¦ ÃÊû
ÇÏ¿© ÀÌ ºÐ¾ßÀÇ Ãֽб¹Á¦ ¿¬±¸µ¿ÇâÀ» ÆÄ¾ÇÇϰí À¯¿ëÇÑ Á¤º¸¸¦
Á¦°øÇϱâ À§ÇØ ¾à¹°À¯Àüü ¿¬±¸ÀÇ ÀÓ»óÀû¿ë¿¡ °üÇÑ ±¹Á¦ ½ÉÆ÷Áö
¿òÀ» °³ÃÖÇÏ°Ô µÇ¾ú½À´Ï´Ù. º» ½ÉÆ÷Áö¿òÀ» ÅëÇÏ¿© ±¹³» ¾à¹°À¯Àü
ü ¿¬±¸°¡ Ȱ¼ºÈ­ µÉ ¼ö ÀÖµµ·Ï ¸¹ÀÌ Âü¼®ÇϽþî À¯¿ëÇÑ Á¤º¸¸¦
½Àµæ ¹× ±³È¯ÇÏ´Â ÁÁÀº ±âȸ°¡ µÇ¾úÀ¸¸é ÇÕ´Ï´Ù


¡Û ÀϽà : 2003. 11. 6(¸ñ) 09:00-18:00

¡Û Àå¼Ò : ±¹¸³º¸°Ç¿ø º¸°Çº¹Áö¿¬¼öºÎ 1Ãþ ´ë°­´ç

¡Û ÁÖÃÖ : ±¹¸³µ¶¼º¿¬±¸¿ø

¡Û ÈÄ¿ø : ½ÄǰÀǾàǰ¾ÈÀüû


½ÉÆ÷Áö¿ò ÇÁ·Î±×·¥


09:00 - 09:30 µî·Ï
ÁøÇà : À¯Å¹«, ±¹¸³µ¶¼º¿¬±¸¿ø ¾àÈ¿¾à¸®°úÀå

09:30 - 09:40 °³È¸»ç
±æ±¤¼· ¿øÀå (±¹¸³µ¶¼º¿¬±¸¿øÀå)

09:40 - 09:50 °Ý·Á»ç
½Éⱸ ûÀå (½ÄǰÀǾàǰ¾ÈÀüûÀå)

ÁÂÀå : À̿뺹±³¼ö (Àü³²´ëÇб³)
10:00 - 10:40 Impact of Pharmacogenomics on Breast
Cancer Treatment
Fred F. Kadlubar, Ph. D (NCTR/FDA, USA)

10:40 - 11:20 Using Pharmacogenetics for Decision Making
and Data Interpretation in Drug Discovery and Development
Wayne H. Anderson, Ph. D (GlaxoSmithKline, USA)

11:20 - 11:50 Pharmacogenetics of Human Flavin-
containing Monooxygenase 3 (FMO3) : Common Polymorphisms in
Korean
Ju-Hee Kang, M.D, Ph.D (Inha University, Korea)

11:50 - 1:30 Á¡ ½É

ÁÂÀå: °­ÁøÇü ±³¼ö (°¡Å縯´ëÇб³)

1:30 - 2:10 Pharmacogenetics: Evolutionary, Functional
and Clinical Aspects Magnus Ingelman-Sundberg, Ph. D
(Karolinska Institute, Sweden)

2:10 - 2:40 Clinical Pharmacogenomics of CYP2D6 and
CYP2C19: Considerations in Clinical Trial and Drug
Development
½ÅÀç±¹±³¼ö (ÀÎÁ¦´ëÇб³)

2:40 - 3:10 Genetic Variation of the Korean Population :
Korean SNP Project for Disease Gene Hunting
ÀÌÁ¾±Ø ¹Ú»ç (À¯Àüü¿¬±¸¼Ò/±¹¸³º¸°Ç¿ø)


3:10 - 3:30 ÈÞ ½Ä


ÁÂÀå : ¼Õµ¿È¯ ±³¼ö (¿ø±¤´ëÇб³)

3:30 - 4:10 SNPs and Haplotypes of Genes Encoding Drug-
Metabolizing Enzymes and Transporters in a Japanese
Population
Jun-ichi Sawada, Ph. D (NIHS, Japan)

4:10 - 4:40 Drug Metabolism Properties by CYP2D6
Genotype in Korean
Á¤¸é¿ì (±¹¸³µ¶¼º¿¬±¸¿ø)

4:40 -5:40 Åä ·Ð
±èÁÖÀÏ (±¹¸³µ¶¼º¿¬±¸¿ø ¾à¸®ºÎÀå)

½ÉÆ÷Áö¿ò µî·Ï Á¤º¸

- µî·Ï
Âü°¡ºñ´Â ¹«·áÀÔ´Ï´Ù.
÷ºÎµÈ Âü°¡½Åû¼­¸¦ ÀÛ¼ºÇÏ½Ã¾î ¾Æ·¡ÀÇ ¿¬¶ôó·Î
º¸³»Áֽʽÿä (11¿ù 5ÀϱîÁö)
ÇöÀåµî·Ïµµ °¡´ÉÇÕ´Ï´Ù.

- ½ÉÆ÷Áö¿ò Á¶Á÷À§¿øÈ¸
½ÄǰÀǾàǰ ¾ÈÀüû ±¹¸³µ¶¼º¿¬±¸¿ø ¾àÈ¿¾à¸®°ú
¼­¿ï½Ã ÀºÆò±¸ ³ì¹øµ¿ 5¹øÁö ¿ì)122-704
Tel. : +82-2-380-1807 / Fax.: +82-2-380-1810
e-mail : swwoo@kfda.go.kr

HOME

¹®¼­ÀÇ Ã³À½À¸·Î